Literature DB >> 9237623

The post-translational modifications of Ral and Rac1 are important for the action of Ral-binding protein 1, a putative effector protein of Ral.

K Matsubara1, T Hinoi, S Koyama, A Kikuchi.   

Abstract

Ral-binding protein 1 (RalBP1) is a putative effector protein of Ral and possesses the GTPase-activating activity for Rac1 and CDC42. We examined the roles of the post-translational modifications of Ral and Rac1 for the action of RalBP1. In COS cells, Ral(G23V), a constitutively active form, was mainly detected in the membrane fraction while most of Ral(G23V/C203S), a Ral mutant which is not post-translationally modified, was found in the cytosol fraction. When RalBP1 was expressed alone in COS cells, it was found in the cytosol but not in the membrane fraction. When RalBP1 was coexpressed with Ral(G23V), a part of RalBP1 was found in the membrane fraction. However, when RalBP1 was coexpressed with Ral(G23V/C203S), all of RalBP1 was recovered in the cytosol fraction. Although Ral bound to RalBP1 at a molar ratio of 1:1, the interaction of Ral with RalBP1 did not affect the GTPase-activating activity of RalBP1 for Rac1. Furthermore, RalBP1 was more active on the post-translationally modified form of Rac1 and CDC42 than the unmodified form. These results suggest that the post-translational modification of Ral is important for the subcellular localization of RalBP1 and that the interaction of Ral with RalBP1 is not essential for the activity of RalBP1 but plays a role in recruiting RalBP1 to the membrane where its substrates, Rac1 and CDC42, reside.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237623     DOI: 10.1016/s0014-5793(97)00633-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector.

Authors:  Nicole F Neel; Kent L Rossman; Timothy D Martin; Tikvah K Hayes; Jen Jen Yeh; Channing J Der
Journal:  Mol Cell Biol       Date:  2012-02-13       Impact factor: 4.272

2.  The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery.

Authors:  Nicole F Neel; Timothy D Martin; Jeran K Stratford; Tanya P Zand; David J Reiner; Channing J Der
Journal:  Genes Cancer       Date:  2011-03

Review 3.  The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.

Authors:  Dillon S Richardson; Jonathan M Spehar; David T Han; Prathik A Chakravarthy; Steven T Sizemore
Journal:  Cells       Date:  2022-05-14       Impact factor: 7.666

4.  RLIP76 regulates Arf6-dependent cell spreading and migration by linking ARNO with activated R-Ras at recycling endosomes.

Authors:  Jeremy G T Wurtzel; Seunghyung Lee; Sharad S Singhal; Sanjay Awasthi; Mark H Ginsberg; Lawrence E Goldfinger
Journal:  Biochem Biophys Res Commun       Date:  2015-10-20       Impact factor: 3.575

5.  RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration.

Authors:  Lawrence E Goldfinger; Celeste Ptak; Erin D Jeffery; Jeffrey Shabanowitz; Donald F Hunt; Mark H Ginsberg
Journal:  J Cell Biol       Date:  2006-09-11       Impact factor: 10.539

6.  Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.

Authors:  Lawrence E Goldfinger; Seunghyung Lee
Journal:  Lung Cancer (Auckl)       Date:  2013

7.  RalGTPases contribute to Schwann cell repair after nerve injury via regulation of process formation.

Authors:  Jorge Galino; Ilaria Cervellini; Ning Zhu; Nina Stöberl; Meike Hütte; Florence R Fricker; Garrett Lee; Lucy McDermott; Giovanna Lalli; David L H Bennett
Journal:  J Cell Biol       Date:  2019-06-14       Impact factor: 10.539

8.  Ral GTPases in Schwann cells promote radial axonal sorting in the peripheral nervous system.

Authors:  Andrea Ommer; Gianluca Figlia; Jorge A Pereira; Anna Lena Datwyler; Joanne Gerber; Jonathan DeGeer; Giovanna Lalli; Ueli Suter
Journal:  J Cell Biol       Date:  2019-06-14       Impact factor: 10.539

Review 9.  RLIP76: A Structural and Functional Triumvirate.

Authors:  Jasmine Cornish; Darerca Owen; Helen R Mott
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

10.  RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer.

Authors:  Hajrah Khawaja; Andrew Campbell; Jamie Z Roberts; Arman Javadi; Paul O'Reilly; Darragh McArt; Wendy L Allen; Joanna Majkut; Markus Rehm; Alberto Bardelli; Federica Di Nicolantonio; Christopher J Scott; Richard Kennedy; Nicolas Vitale; Timothy Harrison; Owen J Sansom; Daniel B Longley; Emma Evergren; Sandra Van Schaeybroeck
Journal:  Cell Death Dis       Date:  2020-10-29       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.